Literature DB >> 14611117

Sarcoid-related uveitis occurring during etanercept therapy.

P J Hashkes1, I Shajrawi.   

Abstract

We report the case of a 7-year-old boy who was initially diagnosed as having polyarticular juvenile idiopathic arthritis. Clinical and laboratory features of overt sarcoidosis became evident early during etanercept therapy when he developed acute panuveitis, papular skin rash and elevated levels of angiotensin-converting enzyme. Non-caseating granulomas were present in the liver. Uveitis resolved upon discontinuation of etanercept and systemic administration of corticosteroids. In rare cases expression of autoimmune disorders or expanded clinical features of these disorders may occur during etanercept treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14611117

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  16 in total

1.  Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab.

Authors:  Peter Korsten; Nadera J Sweiss; Ulf Nagorsnik; Timothy B Niewold; Hermann-Josef Gröne; Oliver Gross; Gerhard A Müller
Journal:  Am J Kidney Dis       Date:  2010-10-25       Impact factor: 8.860

Review 2.  Sarcoid-like granulomatosis in patients treated with anti-TNFα factors. A case report and review of the literature.

Authors:  Theoni Kanellopoulou; Anna Filiotou; Hariklia Kranidioti; Spyridon P Dourakis
Journal:  Clin Rheumatol       Date:  2010-10-23       Impact factor: 2.980

3.  Uveitis associated with sarcoidosis exacerbated by etanercept therapy.

Authors:  Jun Suzuki; Hiroshi Goto
Journal:  Jpn J Ophthalmol       Date:  2009-09-08       Impact factor: 2.447

Review 4.  IL-6 blockade in the management of non-infectious uveitis.

Authors:  Giuseppe Lopalco; Claudia Fabiani; Jurgen Sota; Orso Maria Lucherini; Gian Marco Tosi; Bruno Frediani; Florenzo Iannone; Mauro Galeazzi; Rossella Franceschini; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2017-05-20       Impact factor: 2.980

5.  Sarcoid panuveitis associated with etanercept treatment, resolving with adalimumab.

Authors:  D Dragnev; D Barr; M Kulshrestha; S Shanmugalingam
Journal:  BMJ Case Rep       Date:  2013-09-04

6.  Tumor necrosis factor-alpha (TNF-α)-blockade-induced hepatic sarcoidosis in psoriatic arthritis (PsA): case report and review of the literature.

Authors:  Raquel Cuchacovich; Joseph Hagan; Tahir Khan; Arthur Richert; Luis R Espinoza
Journal:  Clin Rheumatol       Date:  2010-10-01       Impact factor: 2.980

Review 7.  The safety profile of biologic therapies for juvenile idiopathic arthritis.

Authors:  Philip J Hashkes; Yosef Uziel; Ronald M Laxer
Journal:  Nat Rev Rheumatol       Date:  2010-08-31       Impact factor: 20.543

8.  Development of sarcoidosis following etanercept treatment: a report of three cases.

Authors:  Inger Marie Skoie; Klaus Wildhagen; Roald Omdal
Journal:  Rheumatol Int       Date:  2010-01-09       Impact factor: 2.631

9.  Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study.

Authors:  M Rudwaleit; E Rødevand; P Holck; J Vanhoof; M Kron; S Kary; H Kupper
Journal:  Ann Rheum Dis       Date:  2008-07-28       Impact factor: 19.103

10.  Drug-induced uveitis.

Authors:  Nikolas Js London; Sunir J Garg; Ramana S Moorthy; Emmett T Cunningham
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.